Evidence map›Paper›PMID 39846741›Full record

ArticleJournal of virology2025

Mitochondrial injury and complement dysregulation are drivers of pathological inflammation in viral myocarditis.

Yasir Mohamud, Amirhossein Bahreyni, Sinwoo Wendy Hwang, Jingfei Carly Lin, Zhihan Claire Wang, Jingchun Zhang, Honglin Luo

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Zinc: a metallic shield against cardiac inflammation.Metallomics : integrated biometal science · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yasir MohamudCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.ORCID 0000-0002-3950-2070
Amirhossein BahreyniCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Sinwoo Wendy HwangCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Jingfei Carly LinCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Zhihan Claire WangCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Jingchun ZhangCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Honglin LuoCentre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.ORCID 0000-0002-7708-7840

Funding

Canadian Government | Canadian Institutes of Health Research (CIHR) AWD-026469Canadian Government | Canadian Institutes of Health Research (CIHR) PJT-173318,PJT-186101Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2022-02979
6 · The paper itself

Abstract

Enteroviruses cause nearly 1 billion global infections annually and are associated with a diverse array of human illnesses. Among these, myocarditis and the resulting chronic inflammation have been recognized as major contributing factors to virus-induced heart failure. Despite our growing understanding, very limited therapeutic strategies have been developed to address the pathological consequences of virus-induced chronic innate immune activation. Coxsackievirus B3 (CVB3) was used as a model cardiotropic enterovirus. We leveraged IMPORTANCE: This study sheds light on how enteroviruses, specifically coxsackievirus B3, may contribute to heart failure by triggering harmful immune responses in the heart. We discovered that viral infections in heart cells cause mitochondrial damage, which in turn activates a destructive immune response involving the complement system. This immune activation is one of the significant contributors that lead to further injury of heart tissues, worsening the damage caused by the virus. Additionally, we identified key protective molecules that are targeted and disrupted by the virus, allowing the immune system to attack the heart even more aggressively. Understanding these mechanisms may provide additional insights into how viral infections can lead to chronic heart conditions and suggests potential therapeutic targets to prevent or reduce heart damage in patients affected by viral myocarditis.

Indexed as

Complement System ProteinsCoxsackievirus InfectionsEnterovirus B, HumanInflammationMitochondriaMyocarditisAnimalsCD55 AntigensComplement ActivationHumansMacrophagesMaleMiceMice, Inbred C57BLMyocytes, CardiacCD55 AntigensComplement System Proteinscd55cd59complementcoxsackievirus b3heart failureinflammationmitochondriamyocarditis

Identifiers

PMID39846741
PMCPMC11852726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.